FSFlurin Sturzenegger

Flurin Sturzenegger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Flurin Sturzenegger has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chlamydia suis strains exhibit distinct developmental kinetics, coinfection dynamics and tetracycline responses associated with their phylogenetic clade

    by Magdalena de Arriba Sánchez de la Campa, Nadja Fässler, José María Mateos, Flurin Sturzenegger, Joana Delgado-Martins, Hanna Marti, Nicole Borel

    BioStudies – one package for all the data supporting a study

  • Open Access

    Compartmental Profiling of PDE4B in Systemic Sclerosis

    by Astrid Hofman, Pietro Bearzi, Sara Burckhardt, Maryam Asadikorayam, Andrea Laimbacher, Cristian Iperi, Muriel Elhai, Cosimo Bruni, Flurin Struzenegger, Shervin Assassi, et al.

    The preferential phosphodiesterase 4B (PDE4B) inhibitor nerandomilast was recently approved for treatment of idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis. Its proposed immunomodulatory, anti-fibrotic, and endothelial-stabilising actions target all three cardinal features of SSc, yet PDE4B expression has not been systematically characterised in SSc tissue. We aimed to define PDE4B expression across fibrotic organs and cellular compartments in SSc. PDE4B expression was profiled in SSc lung, peripheral blood mononuclear cells (PBMCs) and skin on the transcript level using single-cell RNA sequencing data and on the protein level using immunohistochemistry, immunofluorescence and multiplexed immunofluorescent stainings. PDE4B was consistently dysregulated in immune cells across SSc tissue and PBMCs, with compartment-specific direction and distribution. In SSc-ILD lung, expression was increased in CD8⁺ and CD4⁺ memory T-cells. In PBMCs, expression was increased in B cells, monocytes, and CD8⁺ T-cells, and stratified patients into three endotypes (PDE4Bˡᵒ/ᵐᵉᵈ/hi) not distinguishable by clinical variables. In skin, bulk RNA-seq showed a significant global increase, which localized to myeloid cells in scRNA-seq data. Approximately 90% of FAP⁺ activated fibroblasts co-expressed PDE4B at the protein level in SSc skin, identifying the activated fibroblast compartment as a candidate target for PDE4B inhibition. No PDE4B dysregulation was detected in vascular cell types. This first cell-type-resolved characterisation of PDE4B in SSc demonstrates consistent immune-cell dysregulation across tissues and protein-level enrichment in activated fibroblasts. This provides a human-tissue rationale for the immunomodulatory and anti-fibrotic effects of PDE4B inhibition and supporting PDE4B as a disease-relevant therapeutic target in SSc.

  • Data associated with "Flexible workflows for small volume electron microscopy using resin and Tokuyasu sections"

    by Jose Maria Mateos, Flurin Sturzenegger, Bruno Saraiva, Johannes Riemann, Nicolas Schilling, Jana Doehner, Ricardo Henriques, Andres Kaech, Urs Ziegler

    BioStudies – one package for all the data supporting a study

  • Open Access

    Real-time visualization of STAT activation in live cells using genetically encoded biosensors

    by Thi A. N. Nguyen, Roman Meledin, Karin J. Seubert-Buholzer, Flurin Sturzenegger, Urs Ziegler, Ufuk Karakus, Onur Boyman

    Signal transducer and activator of transcription (STAT) is a family of key transcriptional regulators in immune, epithelial and mesenchymal cells. Aberrant STAT activity is associated with malignancy, autoimmunity and immunodeficiency. The STAT signaling pathways are very attractive drug targets; however, validated tools to monitor real-time activation of STATs are lacking. Here, we developed a class of highly sensitive genetically encoded STAT biosensors, termed STATeLights, which allowed direct and continuous detection of STAT activity in live cells with high spatiotemporal resolution. Using human STAT5A, we demonstrate the versatility of STATeLight5A to quantify the activation of wild-type STAT5 versus disease-associated STAT5 mutants and to precisely select compounds targeting the STAT5 signaling pathway. Moreover, STATeLight5A also facilitated real-time tracking of STAT5 activation in human primary CD4 + T cells. Collectively, our biosensors open up unprecedented possibilities of studying STAT biology and druggability in various cellular contexts.


  • GM-CSF derived from alveolar type 2 cells promotes CD301b + cDC2 generation and allergic airway inflammation

    by Julia Gschwend, Antonie Lechner, Nikolaos D. Sidiropoulos, Paul Maier, Tilde Andersson, Flurin Sturzenegger, Basak Corak, Nina Brander, David A. Bejarano, Elina Wells, et al.

    Pulmonary conventional dendritic cells (cDCs) are functionally and phenotypically heterogeneous antigen-presenting cells essential for orchestrating adaptive immune responses in the lung. Here, we define a cell-intrinsic role for granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling in the development of a CD301b + subset of terminally differentiated cDC2s, in addition to CD103 + XCR1 + cDC1s. Unbiased single-cell transcriptomic profiling of CD11c + cells identified both immature and differentiated lung cDC populations. GM-CSF deficiency disrupted antiapoptotic Bcl2a1 up-regulation and impaired progression to the CD301b + transcriptional state. Despite the positioning of CD301b + cDC2s in lymphoid cell–rich adventitial cuff areas, hematopoietic GM-CSF was dispensable for their development. Instead, alveolar epithelial type 2 cell–derived GM-CSF was required for CD301b + cDC2 formation and pulmonary type 2 immune responses, highlighting the central role of GM-CSF signaling in shaping the pulmonary myeloid landscape.


  • Single-Molecule FRET at 10 MHz Count Rates

    by Lennart Grabenhorst, Flurin Sturzenegger, Moa Hasler, Benjamin Schuler, Philip Tinnefeld

    A bottleneck in many studies utilizing single-molecule Förster resonance energy transfer is the attainable photon count rate, as it determines the temporal resolution of the experiment. As many biologically relevant processes occur on time scales that are hardly accessible with currently achievable photon count rates, there has been considerable effort to find strategies to increase the stability and brightness of fluorescent dyes. Here, we use DNA nanoantennas to drastically increase the achievable photon count rates and observe fast biomolecular dynamics in the small volume between two plasmonic nanoparticles. As a proof of concept, we observe the coupled folding and binding of two intrinsically disordered proteins, which form transient encounter complexes with lifetimes on the order of 100 μs. To test the limits of our approach, we also investigated the hybridization of a short single-stranded DNA to its complementary counterpart, revealing a transition path time of 17 μs at photon count rates of around 10 MHz, which is an order-of-magnitude improvement compared to the state of the art. Concomitantly, the photostability was increased, enabling many seconds long megahertz fluorescence time traces. Due to the modular nature of the DNA origami method, this platform can be adapted to a broad range of biomolecules, providing a promising approach to study previously unobservable ultrafast biophysical processes.